Katherine Deland1, Joshua S Mercer1, Donna M Crabtree2, Maria E Guerra Garcia1, Michael Reinsvold1, Lorraine Da Silva Campos1, Nerissa T Williams1, Lixia Luo1, Yan Ma1, Zachary J Reitman1, Oren J Becher3, David G Kirsch4. 1. Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina. 2. Department of Pediatrics, Duke University Medical Center, Durham, North Carolina. 3. Department of Pediatrics, Northwestern University, Chicago, Illinois; Department of Biochemistry and Molecular Genetics, Northwestern University, Chicago, Illinois; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois. 4. Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina; Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, North Carolina. Electronic address: david.kirsch@duke.edu.
Abstract
PURPOSE: Diffuse intrinsic pontine gliomas (DIPGs) arise in the pons and are the leading cause of death from brain tumors in children. DIPGs are routinely treated with radiation therapy, which temporarily improves neurological symptoms but generally fails to achieve local control. Because numerous clinical trials have not improved survival from DIPG over standard radiation therapy alone, there is a pressing need to evaluate new therapeutic strategies for this devastating disease. Vascular damage caused by radiation therapy can increase the permeability of tumor blood vessels and promote tumor cell death. METHODS AND MATERIALS: To investigate the impact of endothelial cell death on tumor response to radiation therapy in DIPG, we used dual recombinase (Cre + FlpO) technology to generate primary brainstem gliomas which lack ataxia telangiectasia mutated (Atm) in the vasculature. RESULTS: Here, we show that Atm-deficient tumor endothelial cells are sensitized to radiation therapy. Furthermore, radiosensitization of the vasculature in primary gliomas triggered an increase in total tumor cell death. Despite the observed increase in cell killing, in mice with autochthonous DIPGs treated with radiation therapy, deletion of Atm specifically in tumor endothelial cells failed to improve survival. CONCLUSIONS: These results suggest that targeting the tumor cells, rather than endothelial cells, during radiation therapy will be necessary to improve survival among children with DIPG.
PURPOSE: Diffuse intrinsic pontine gliomas (DIPGs) arise in the pons and are the leading cause of death from brain tumors in children. DIPGs are routinely treated with radiation therapy, which temporarily improves neurological symptoms but generally fails to achieve local control. Because numerous clinical trials have not improved survival from DIPG over standard radiation therapy alone, there is a pressing need to evaluate new therapeutic strategies for this devastating disease. Vascular damage caused by radiation therapy can increase the permeability of tumor blood vessels and promote tumor cell death. METHODS AND MATERIALS: To investigate the impact of endothelial cell death on tumor response to radiation therapy in DIPG, we used dual recombinase (Cre + FlpO) technology to generate primary brainstem gliomas which lack ataxia telangiectasia mutated (Atm) in the vasculature. RESULTS: Here, we show that Atm-deficient tumor endothelial cells are sensitized to radiation therapy. Furthermore, radiosensitization of the vasculature in primary gliomas triggered an increase in total tumor cell death. Despite the observed increase in cell killing, in mice with autochthonous DIPGs treated with radiation therapy, deletion of Atm specifically in tumor endothelial cells failed to improve survival. CONCLUSIONS: These results suggest that targeting the tumor cells, rather than endothelial cells, during radiation therapy will be necessary to improve survival among children with DIPG.
Authors: Francisco J Cordero; Zhiqing Huang; Carole Grenier; Xingyao He; Guo Hu; Roger E McLendon; Susan K Murphy; Rintaro Hashizume; Oren J Becher Journal: Mol Cancer Res Date: 2017-05-18 Impact factor: 5.852
Authors: Jackelyn A Alva; Ann C Zovein; Arnaud Monvoisin; Thomas Murphy; Anthony Salazar; Natasha L Harvey; Peter Carmeliet; M Luisa Iruela-Arispe Journal: Dev Dyn Date: 2006-03 Impact factor: 3.780
Authors: Shan Zha; Wenxia Jiang; Yuko Fujiwara; Harin Patel; Peter H Goff; James W Brush; Richard L Dubois; Frederick W Alt Journal: Proc Natl Acad Sci U S A Date: 2011-01-18 Impact factor: 11.205
Authors: Everett J Moding; Chang-Lung Lee; Katherine D Castle; Patrick Oh; Lan Mao; Shan Zha; Hooney D Min; Yan Ma; Shiva Das; David G Kirsch Journal: J Clin Invest Date: 2014-07-18 Impact factor: 14.808
Authors: Katherine Deland; Bryce F Starr; Joshua S Mercer; Jovita Byemerwa; Donna M Crabtree; Nerissa T Williams; Lixia Luo; Yan Ma; Mark Chen; Oren J Becher; David G Kirsch Journal: J Clin Invest Date: 2021-01-04 Impact factor: 14.808
Authors: Dong-Anh Khuong-Quang; Pawel Buczkowicz; Patricia Rakopoulos; Xiao-Yang Liu; Adam M Fontebasso; Eric Bouffet; Ute Bartels; Steffen Albrecht; Jeremy Schwartzentruber; Louis Letourneau; Mathieu Bourgey; Guillaume Bourque; Alexandre Montpetit; Genevieve Bourret; Pierre Lepage; Adam Fleming; Peter Lichter; Marcel Kool; Andreas von Deimling; Dominik Sturm; Andrey Korshunov; Damien Faury; David T Jones; Jacek Majewski; Stefan M Pfister; Nada Jabado; Cynthia Hawkins Journal: Acta Neuropathol Date: 2012-06-03 Impact factor: 17.088
Authors: Matthew Gallitto; Stanislav Lazarev; Isaac Wasserman; James M Stafford; Suzanne L Wolden; Stephanie A Terezakis; Ranjit S Bindra; Richard L Bakst Journal: Adv Radiat Oncol Date: 2019-03-30